NGAL Mediates Anaplastic Thyroid Carcinoma Cells survival Through FAS/CD95 Inhibition. Crescenzi E, Mellone S, Gragnano G, Iaccarino A, et al. Endocrinology 2023 Dec 13:bqad190. doi: 10.1210.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Crescenzi E, Mellone S, Gragnano G, Iaccarino A, et al. NGAL Mediates Anaplastic Thyroid Carcinoma Cells survival Through FAS/CD95 Inhibition. Endocrinology 2023 Dec 13:bqad190. doi: 10.1210.
PMID: 38091978